Suppression of amphiregulin/epidermal growth factor receptor signals contributes to the protective effects of quercetin in cirrhotic rats

Journal of Nutrition

Volumn 141, Issue 7, 2011, Pages 1299-1305

  Cuevas, María J ^a   Tieppo, Juliana ^b   Marroni, Norma Possa ^b,c   Tuñón, María J ^a   González Gallego, Javier ^a  

^a UNIVERSITY OF LEÓN   (Spain)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^c UNIVERSIDADE LUTERANA DO BRASIL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHIREGULIN; CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR; INTERLEUKIN 6; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR; PROTEIN KINASE B; QUERCETIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; CELL GROWTH; COMMON BILE DUCT; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; EXPERIMENTAL LIGATION; EXPERIMENTAL LIVER CIRRHOSIS; GENE OVEREXPRESSION; GLI1 GENE; GLI2 GENE; LIVER CELL; LIVER EXAMINATION; LIVER PROTECTION; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; RAT; RECEPTOR BLOCKING; SHAM PROCEDURE; SIGNAL TRANSDUCTION;

ANIMALS; CELL PROLIFERATION; CELL SURVIVAL; CYCLOOXYGENASE 2; CYTOKINES; GLYCOPROTEINS; GROWTH SUBSTANCES; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; QUERCETIN; RATS; RATS, WISTAR; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, MESSENGER; SIGNAL TRANSDUCTION; UP-REGULATION;

RATTUS;

EID: 79960290467     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.111.140954     Document Type: Article

References (49)

1. Kountouras J, Billing BH, Scheuer PJ. Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat. Br J Exp Pathol. 1984;65:305-11.
2. Chang ML, Yeh CT, Chang PY, Chen JC. Comparison of murine cirrhosis models induced by hepatotoxin administration and common bile duct ligation. World J Gastroenterol. 2005;11:4167-72.
3. Taub R. Liver regeneration: from myth to mechanism. Nat Rev Mol Cell Biol. 2004;5:836-47.
4. Fausto N, Campbell JS, Riehle KJ. Liver regeneration. Hepatology. 2006;43:(2 Suppl.1);S45-53.
5. Carver RS, Stevenson MC, Scheving LA, Russell WE. Diverse expression of ErbB receptor proteins during rat liver development and regeneration. Gastroenterology. 2002;123:2017-27.
6. Berasain C, García-Trevijano ER, Castillo J, Erroba E, Santamaría M, Lee DC, Prieto J, Avila MA. Novel role for amphiregulin in protection from liver injury. J Biol Chem. 2005;280:19012-20.
7. Berasain C, Castillo J, Perugorría MJ, Prieto J, Ávila MA. Amphiregulin: a new growth factor in hepatocarcinogenesis. Cancer Lett. 2007;254:30-41.
8. Höpfner M, Schuppan D, Scherübl H. Growth factor receptors and related signaling pathways as targets for novel treatment strategies of hepatocellular cancer. World J Gastroenterol. 2008;14:1-14.
9. Castillo J, Erroba E, Perugorría MJ, Santamaría M, Lee DC, Prieto J, Avila MA, Berasain C. Amphiregulin contributes to the transformed phenotype of human hepatocellular carcinoma cells. Cancer Res. 2006;66:6129-38.
10. Schiffer E, Housset C, Cacheux W, Wendum D, Desbois-Mouthon C, Rey C, Clergue F, Poupon R, Barbu V, et al. Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis. Hepatology. 2005;41:307-14.
11. Giannelli G, Azzariti A, Fransvea E, Porcelli L, Antonaci S, Paradiso A. Laminin-5 offsets the efficacy of gefitinib ("Iressa") in hepatocellular carcinoma cells. Br J Cancer. 2004;91:1964-9.
12. Berasain C, Castillo J, Perugorria MJ, Latasa MU, Prieto J, Avila MA. Inflammation and liver cancer: new molecular links. Ann N Y Acad Sci. 2009;1155:206-21.
13. González-Gallego J, García-Mediavilla MV, Sánchez-Campos S, Tuñón MJ. Fruit polyphenols, immunity and inflammation. Br J Nutr. 2010;104 Suppl 3:15-27.
14. Lee LT, Huang YT, Hwang JJ, Lee PP, Ke FC, Nair PM, Kanadaswam C, Lee MT. Blockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumour cells. Anticancer Res. 2002;22:1615-27.
15. Huang YT, Hwang JJ, Lee PP, Huang JH, Huang CJ, Kandaswami C, Middleton E, Lee MT. Effects of luteolin and quercetin, inhibitors of tyrosine kinase, on cell growth and metastasis-associated properties in A431 cells overexpressing epidermal growth factor receptor. Br J Pharmacol. 1999;128:999-1010.
16. Fridrich D, Teller N, Esselen M, Pahlke G, Marko D. Comparison of delphinidin, quercetin and (-)-epigallocatechin-3-gallate as inhibitors of the EGFR and ErbB2 receptor phosphorylation. Mol Nutr Food Res. 2008;52:815-22.
17. Jung JH, Lee JO, Kim JH, Lee SK, You GY, Park SH, Park JM, Kim EK, Suh PG, et al. Quercetin suppresses HeLa cell viability via AMPKinduced HSP70 and EGFR down-regulation. J Cell Physiol. 2010;223: 408-14.
18. Peres W, Tuñón MJ, Collado PS, Herrmann S, Marroni N, González-Gallego J. The flavonoid quercetin ameliorates liver damage in rats with biliary obstruction. J Hepatol. 2000;33:742-50.
19. Tieppo J, Cuevas MJ, Vercelino R, Tuñon MJ, Marroni NP, Gonzalez-Gallego J. Prevention of hepatopulmonary syndrome by quercetin administration in cirrhotic rats. J Nutr. 2009;139:1339-46.
20. Muriel P, Suárez OR, González P, Zúñiga L. Protective effect of S-adenosyl-1-methionine on liver damage induced by biliary obstruction in rats: a histological, ultrastructural and biochemical approach. J Hepatol. 1994;21:95-102.
21. Lee TY, Lee KC, Chang HH. Modulation of the cannabinoid receptors by andrographolide attenuates hepatic apoptosis following bile duct ligation in rats with fibrosis. Apoptosis. 2010;15:904-14.
22. Crespo I, Garcia-Mediavilla MV, Almar M, González P, Sánchez-Campos S, TuñónMJ, González-Gallego J. Differential effects of dietary flavonoids on reactive oxygen and nitrogen species generation and antioxidant enzymes in Chang Liver cells. Food Chem Toxicol. 2008;46:1555-69.
23. Moreira AJ, Fraga C, Alonso M, Collado PS, Zettler C, Marroni C, González-Gallego J. Quercetin prevents oxidative stress and NF-kappaB activation in gastric mucosa of portal hypertensive rats. Biochem Pharmacol. 2004;68:1939-46.
24. Feitelson MA, Sun B, Satiroglu-Tufan NL, Liu J, Pan J, Lian Z. Genetic mechanisms of hepatocarcinogenesis. Oncogene. 2002;21:2593-604.
25. Natarajan A, Wagner B, Sibilia M. The EGF receptor is required for efficient liver regeneration. Proc Natl Acad Sci USA. 2007;104: 17081-6.
26. Napoli J, Prentice D, Niinami C, Bishop GA, Desmond P, McCaughan GW. Sequential increases in the intrahepatic expression of epidermal growth factor, basis fibroblast growth factor, and transforming growth factor beta in a bile duct ligated rat model of cirrhosis. Hepatology. 1997;26:624-33.
27. Whittaker S, Marais R, Zhu AX. The role of signaling pathways in the development and treatment of hepatocellular carcinoma. Oncogene. 2010;29:4989-5005.
28. Miyazaki Y, Hiraoka S, Tsutsui S, Kitamura S, Shinomura Y, Matsuzawa Y. Epidermal growth factor receptor mediates stressinduced expression of its ligands in rat gastric epithelial cells. Gastroenterology. 2001;120:108-16.
29. Wagenaar GT, ter Horst SA, van Gastelen MA, Leijser LM, Mauad T, van der Velden PA, de Heer E, Hiemstra PS, Poorthuis BJ, et al. Gene expression profile and histopathology of experimental bronchopulmonary dysplasia induced by prolonged oxidative stress. Free Radic Biol Med. 2004;36:782-801.
30. Fukumoto J, Haracda C, Kawaguchi T, Suetsugu S, Maeyama T, Inoshima I, Hamada N, Kuwano K, Nakanishi Y. Amphiregulin attenuates belomycin-induced pneumopathy in mice. Am J Physiol Lung Cell Mol Physiol. 2010;298:L131-8.
31. Berasain C, García-Trevijano ER, Castillo J, Erroba E, Lee DC, Prieto J, Avila MA. Amphiregulin: an early trigger for liver regeneration in mice. Gastroenterology. 2005;128:424-32.
32. Perugorria MJ, Latasa MJ, Nicou A, Cartagena H, Castillo J, Goñi S, Vespasiani-Gentilucci U, Zagami MG, Loretsztajn S, et al. The epidermal growth factor receptor ligand amphiregulin participates in the development of mouse liver fibrosis. Hepatology. 2008;48: 1251-61.
33. Yotsumoto F, Fukami T, Yagi H, Funakoshi A, Yoshizato T, KurokiM, Myamoto S. Amphiregulin regulates the activation of ERK and Akt through epidermal growth factor receptor and HER3 signals involved in the progression of pancreatic cancer. Cancer Sci. 2010; 101:2351-60.
34. Kern M, Tjaden Z, Ngiewih Y, Puppel N, Will F, Dietrich H, Pahlke G, Marko D. Inhibitors of the epidermal growth factor receptor in apple juice extract. Mol Nutr Food Res. 2005;49:317-28.
35. Granado-Serrano AB, Martín MA, Bravo L, Goya L, Ramos S. Quercetin induces apoptosis via caspase activation, regulation of Bcl-2, and inhibition of PI-3-kinase/Akt and ERK pathways in a human hepatoma cell line (HepG2). J Nutr. 2006;136:2715-21.
36. Liu M, Yang SC, Sharma S, Luo J, Cui X, Peebles KA, Huang M, Sato M, Ramirez RD, et al. EGFR signaling is required for TGF-beta 1 mediated COX-2 induction in human bronchial epithelial cells. Am J Respir Cell Mol Biol. 2007;37:578-88.
37. Shao MX, Ueki IF, Nadel JA. Tumor necrosis factor alphaconverting enzyme mediates MUC5AC mucin expression in cultured human airway epithelial cells. Proc Natl Acad Sci USA. 2003;100: 11618-23.
38. Chokki M, Mitsuhashi H, Kamimura T. Metalloprotease-dependent amphiregulin release mediates tumor necrosis factor-a-induced IL-8 secretion in the human airway epitelial cell line NCI-H2929. Life Sci. 2006;78:3051-7.
39. Feng PH, Hsiung TC, Kuo HP, Huang CD. Cross-tal between bradykinin and epidermal growth factor in regulating IL-6 production in human airway smooth muscle cells. Chang Gung Med. 2010;33:92-9.
40. Sisto M, Lisi S, Lofrumento DD, Mitolo V, D'Amore M. Blockade of TNF-a signaling supresses the AREG-mediated IL-6 and IL-8 cytokines secretion induced by anti-Ro/SSA. Lab Invest. Epub 2010 Sep 20.
41. Breuhahn K, Longerich T, Schirmacher P. Dysregulation of growth factor signaling in human hepatocellular carcinoma. Oncogene. 2006; 25:3787-800.
42. Wu J, Zern MA. Hepatic stellate cells: a target for the treatment of liver fibrosis. J Gastroenterol. 2000;35:665-72.
43. Matsuzaki K, Murata M, Yoshida K, Sekimoto G, Uemura Y, Sakaida N, Kaibori M, Kamiyama Y, Nishizawa M, et al. Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor β signaling, promoting cirrhosis and hepatocellular carcinoma. Hepatology. 2007;46:48-57.
44. Ruiz i Altaba A, Mas C, Stecca B. The Gli code: an information nexus regulating cell fate, stemness and cancer. Trends Cell Biol. 2007;17: 438-47.
45. Lauth M, Toftgard R. Non-canonical activation of GLI transcription factors: implications for targeted anticancer therapy. Cell Cycle. 2007;6:2458-63.
46. Dennler S, André J, Verrecchia F, Mauviel A. Cloning of the human GLI2 Promoter: transcriptional activation by transforming growth factor-beta via SMAD3/beta-catenin cooperation. J Biol Chem. 2009; 284:31523-31.
47. Schnidar H, Eberl M, Klingler S, Mangelberger D, Kasper M, Hauser-Kronberger C, Regl G, Kroismayr R, Moriggl R, et al. Epidermal growth factor receptor signaling synergizes with Hedgehog/GLI in oncogenic transformation via activation of the MEK/ERK/JUN pathway. Cancer Res. 2009;69:1284-92.
48. Slusarz A, Shenouda NS, Sakla MS, Drenkhahn SK, Narula AS, MacDonald RS, Besch-Williford CL, Lubahn DB. Common botanical compounds inhibit the hedgehog signaling pathway in prostate cancer. Cancer Res. 2010;70:3382-90.
49. Tsujioka H, Yotsumoto F, Shiroka K, Horiuchi S, Yoshizato T, Kuroki M, Myamoto S. Emerging strategies for Erb B ligand-based targeted therapy for cancer. Anticancer Res. 2010;30:3107-12.